Synthesis and antimicrobial assessment uncover potential of new compounds against microbes, suggesting therapeutic applications.
Objective: This work highlights the potential of 2-oxopyridine and imidazole blends as powerful medicinal agents by examining their antibacterial properties. Because of their many therapeutic uses, such as antifungal, anticancer, antibacterial, antiviral, and antihypertensive properties, 2-oxopyridine and imidazole derivatives have garnered significant attention. Methodology: A reliable synthetic process was created to produce a number of chemicals 5a–5s in order to investigate their potential for therapeutic use. With the use of sophisticated analytical methods like LC-MS, 1H NMR, and elemental analysis, the structures of the recently synthesized compounds were verified. Additionally, the antibacterial effectiveness of each produced molecule was evaluated against a variety of Gram-positive and Gram-negative species. Results and Discussion: The synthesized compounds showed variable antibacterial activity. Halogen-substituted derivatives, particularly iodinated and fluorinated analogues, exhibited enhanced Gram-positive and Gram-negative inhibition, indicating substitution-dependent structure–activity relationships. Conclusion: This study opens the door for further research into the clinical implications of 2-oxopyridine and imidazole blends for treating microbial problems by offering insightful information about their therapeutic potential.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: